SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Endo Pharmaceuticals Announces Reformulated Version of OPANA® ER With INTAC® Technology Designed to be Crush-Resistant Accounts for More Than 90 Percent of OPANA ER Total Prescription Volume